Sat, Oct 25, 2014, 11:49 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • kvnmccdd kvnmccdd Apr 1, 2013 4:46 PM Flag

    Insmed Appoints Matthew Pauls as Chief Commercial Officer

    Insmed Appoints Matthew Pauls as Chief Commercial Officer

    20-Year Industry Veteran Brings Global Sales, Marketing and Reimbursement Expertise From Leading Pharmaceutical Companies

    MONMOUTH JUNCTION, NJ -- (Marketwire) -- 04/01/13 -- Insmed Incorporated (NASDAQ: INSM), a biopharmaceutical company focused on developing and commercializing inhaled therapies for patients battling serious lung diseases in orphan indications that are often life-threatening, announces the appointment of Matthew Pauls as Chief Commercial Officer. In this newly created position, Mr. Pauls reports to Will Lewis, President and Chief Executive Officer, and has full global commercial responsibility for ARIKACE®, liposomal amikacin for inhalation, which is under development to treat Pseudomonas aeruginosa lung infections in cystic fibrosis (CF) patients and patients with non-tuberculous mycobacteria (NTM) lung infections.

    The Sbashers are slowly dying now.......soon very soon!

    Until Then!

    Sentiment: Strong Buy

 
INSM
14.27-0.06(-0.42%)Oct 24 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
SodaStream International Ltd.
NasdaqGSFri, Oct 24, 2014 4:00 PM EDT
KLA-Tencor Corporation
NasdaqGSFri, Oct 24, 2014 4:00 PM EDT
Ford Motor Co.
NYSEFri, Oct 24, 2014 4:00 PM EDT